Antimony

If you live near busy traffic, work in a setting that handles metals, batteries, brake linings, or flame-retardant materials, or simply want to know what your body has absorbed from the environment, this test gives you a direct read. Antimony is a toxic metalloid (an element with properties between a metal and a nonmetal) that has no useful job in your body, and the only reason it shows up in your blood is exposure from the outside world.

Most people will never have this tested unless they have a specific reason. For people with a meaningful exposure profile, a baseline can be useful, because emerging human studies link higher antimony exposure to heart disease, glucose problems, cognitive decline, and sleep disorders. These findings are largely from observational studies using urinary antimony, so the test is best understood as an exposure check rather than a diagnostic of any specific disease.

What Antimony Actually Is

Antimony (Sb) is a silvery-white metalloid used widely in industry, including metal alloys, batteries, and fireproofing materials. It enters people mainly through breathing, eating, and drinking. After inhalation exposure, lung tissue holds the highest concentrations with a very long retention time. After exposure through food or water, the spleen, bone, thyroid, liver, and kidneys are the main sites of accumulation. Antimony can also bind to red blood cells, and it leaves the body slowly through urine and stool.

Your body does not produce antimony, and you do not need any. So when it appears in a blood test, the level is essentially a stamp of how much you have absorbed from outside sources. Common sources include coal combustion, waste incineration, mining and smelting, vehicle emissions, shooting activity, household smoking, and products made with antimony-containing materials.

One nuance worth knowing: antimony exists in different chemical forms (mainly Sb(III) and Sb(V)), and the Sb(III) form is considered much more biologically active and toxic. Standard blood and urine tests usually report total antimony rather than separating the forms, so the number you see is the sum of everything in circulation.

Heart Disease Risk

The strongest emerging human signal for environmental antimony exposure is cardiovascular. In a large Danish prospective study of non-smokers, people in the highest quartile of urinary antimony were about 1.5 times as likely to develop a heart attack and about 1.6 times as likely to develop heart failure compared with the lowest quartile.

Population data from the United States reinforce this pattern. Analyses from a national health survey found that adults in the highest exposure quartile had roughly twice the odds of self-reported congestive heart failure and about 1.8 times the odds of heart attack compared with the lowest quartile. Heart disease mortality was also elevated, with people in the third exposure quartile showing about 2.2 times the risk.

Most of this evidence comes from urinary antimony measurements rather than blood. Blood and urine track different windows of exposure, but they are biologically connected: blood reflects recent and ongoing exposure, while urine reflects what your body is clearing. If your blood antimony is elevated, the same exposure source is generally driving both measurements, though the underlying pharmacokinetics involve multiple body compartments and are not a simple one-to-one translation.

Glucose and Metabolic Health

Antimony appears to interfere with how the body handles glucose. In adolescents, higher urinary antimony was associated with higher hemoglobin A1c, a measure of average blood sugar over the past three months. After full adjustment, A1c was meaningfully higher in teens with greater antimony exposure, with the highest exposure tertile showing the largest difference compared with the lowest tertile.

The relationship was stronger in males and showed a steady dose-response pattern, meaning that as exposure went up, blood sugar markers went up too. Adult studies have separately suggested links between antimony and type 2 diabetes risk, supported by laboratory work showing antimony can disrupt glucose-regulating cells in the gut. The adolescent data currently offer the cleanest exposure-response signal in humans.

Cognitive Decline and Sleep

A prospective Chinese cohort study of older adults found that the risk of cognitive impairment increased by about 56 percent for each e-fold rise in urinary antimony, meaning that even modest increases in exposure tracked with meaningful cognitive risk over follow-up.

The picture is not perfectly linear. A US analysis of older adults found that very low antimony levels were associated with somewhat better cognitive performance, while only higher levels were tied to impairment. The takeaway is that the strongest concerns sit at the higher end of exposure rather than across the full range.

Antimony has also been linked to disrupted sleep. In a national health survey, higher urinary antimony was associated with about 1.6 times the odds of obstructive sleep apnea, plus higher reports of insufficient sleep and daytime sleepiness. The mechanism is not settled, but both signals point to systemic effects beyond the heart.

Occupational Lung and Cancer Risk

People exposed to antimony at work, especially through inhalation in smelting, mining, or brake-lining manufacturing, can develop respiratory irritation and a specific form of dust-related lung disease sometimes called antimoniosis. Chronic inhalation has also been linked to abnormal electrocardiograms, stomach pain, and worsened lung and heart disease.

Cancer evidence is more mixed. Animal evidence for inhaled antimony trioxide causing lung tumors is described as sufficient, but human worker evidence is still considered inadequate because of small studies, confounding from co-exposures, and uncertain dose thresholds. Antimony trioxide is currently classified by IARC as possibly carcinogenic to humans (group 2B). It is plausibly carcinogenic through inhalation in occupational settings, but a single low-level blood reading does not translate directly to personal cancer risk.

Treatment-Related Toxicity

In parts of the world where pentavalent antimony is used to treat leishmaniasis, the drug itself causes measurable cardiotoxicity in about 9 percent of treated patients and can also cause pancreatitis. This setting is different from environmental exposure, but it shows that the body responds to antimony in dose-dependent ways.

Why One Reading Is Not Enough

Antimony in blood reflects recent exposure rather than a stable internal pool. Levels can move with changes in your environment: a new job, a move closer to or further from a busy road, a change in household smoking, even a season of heavier shooting activity or industrial work nearby. A single number is a snapshot, not a verdict.

Tracking your trend is more useful than any single reading. There are no clinical guidelines for how often to retest antimony in the general population, so the cadence is a judgment call. A practical approach is to get a baseline, retest after a meaningful change in your environment or occupation, and check periodically if you live in an area with known exposure sources. Population data from Germany show that average exposure in children fell roughly 50 percent between 2003 to 2006 and 2014 to 2017, which means broad environmental policy and personal choices can both shift these numbers over time.

When Results Can Be Misleading

Antimony testing is a research-grade measurement without universally standardized clinical cutpoints, so the same sample can read differently across labs depending on the assay used. A few specific situations to keep in mind:

• Kidney function changes: in people on hemodialysis, antimony levels shifted with dialysis duration and clearance efficiency, which means severe kidney disease can affect how your body holds onto and clears the metalloid.
• Recent acute exposure: if you were exposed to antimony in the days before testing (a workplace incident, an unusually dusty environment, or shooting activity), the reading can spike temporarily and not reflect your baseline.
• Specimen and form differences: blood antimony captures recent circulating metalloid, while urine captures what your body is actively clearing. Studies in the literature mostly use urine, so blood interpretation is best done alongside repeated measurement.
• Lab method variation: different analytical techniques can produce different readings for the same sample, so using the same lab over time gives you the cleanest trend.

Decision Pathway for an Unexpected Result

If your antimony comes back higher than expected, the first step is exposure detective work, not panic. Ask: do you live near a major roadway, smelter, or coal-fired facility? Does anyone in your household smoke? Do you work with metals, batteries, brake parts, ammunition, or flame-retardant materials? Have you spent significant time recently in dusty industrial or shooting environments?

Order companion tests to round out the picture: a urinary heavy metals panel can show what your body is actively clearing, and other metals on a broader panel can reveal whether the exposure is isolated to antimony or part of a wider environmental signal. Because antimony tracks with cardiovascular and metabolic risk in human studies, pairing it with a fasting glucose, hemoglobin A1c, lipid panel, and blood pressure check makes sense if those are not already current.

A consistently elevated result warrants a conversation with a medical toxicologist or occupational health specialist, especially if you have any workplace exposure. Removing the exposure source is the highest-leverage step. Chelation therapy is sometimes used for confirmed heavy-metal toxicity, but it carries its own side effects and should never be a first move based on a single ambiguous reading.